bullish

Eoflow

EOFlow (294090 KS): Suitably Pumped

568 Views23 May 2024 12:08
EOFlow is free to resume global sales. Medtronic is free to reengage. I'd be buying EOFlow. Then I'd buy some more. I'd be shorting Insulet.
What is covered in the Full Insight:
  • Overview of EOFlow-Insulet Legal Dispute
  • Current Status of the Preliminary Injunction
  • Future Prospects for EOFlow
  • Medtronic's Interest in EOFlow
  • EOFlow's Possible Future without Medtronic
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 10-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
David Blennerhassett
Pan-Asia Catalysts/Events
Quiddity Advisors
EquitiesEvent-Driven
Price Chart(Sign Up to Access)
analytics-chart
x